Delivered-To: josh@josh.is
Received: by 2002:a2e:9f09:0:0:0:0:0 with SMTP id u9csp340454ljk;
        Sat, 11 Apr 2020 05:17:57 -0700 (PDT)
X-Received: by 2002:ac8:4885:: with SMTP id i5mr3380306qtq.305.1586607477626;
        Sat, 11 Apr 2020 05:17:57 -0700 (PDT)
ARC-Seal: i=1; a=rsa-sha256; t=1586607477; cv=none;
        d=google.com; s=arc-20160816;
        b=m9caBzWs6wSrVTSHtpx6qIrLaqDSg8HVAH3yTmKyKBDM2SOoJFGA/uJ0kKwude4PV1
         IE7KvIyCInqSTXJZ60ya93OKW1dbCj6U8vvSjvt1ikoBYPjhpuuUNaOl733fXQYfjv9L
         cCuGIMh2Wx5XW9HFKN7JT5LKLMpikaeRgn8kZUk4Xso72mDGc7ZcELX1iLzizN8+gZ99
         RQJ/OqTrKVETNo7UCHdnK2q/p6wIDgaTZ0ae2n22ZNqp3LCpVcUR+MWjlKgjXgPL6tYV
         AQqbSoNorQscYX25oQRP7/InRgi8FK5qrzpqiu4qCeHzzPJaXQ9db8MkFjBDr14VKAHj
         zVMg==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816;
        h=to:message-id:subject:date:mime-version:content-transfer-encoding
         :from:dkim-signature;
        bh=O2tvPxJjUEQcqtf7Ql+o/9C5dUgclQDTO0bXqiOMEgU=;
        b=f7RqtndzMO5OQxk53r4H71Y4WYnamDvuUzwBifq8yRmU41qRsKof/RLB1ZJvs416mP
         fWuafOSXXSimKiOEczLL8A0GmNULRc4Z83HRoEsocdLnZ2scmm5xSAVYK5utWR8UN9g6
         BF2wkscbuVYP408mOelgeEfG6Bq9GSTp5e3z62ti5SD5jHhdPniwFPeRO2AW/1zBksSB
         loIyh5YmYDuGg+ba1g0NRxgThE85RcBzcTcp1xARjL9VBe8fFv40XWhd67b+pCwAUM5Q
         3niOx24MEjaFko59j/xqijB3Yq93a9zYskbLlVx65j3x4OW8Dy0quopONUOxXJts4u/h
         V3LA==
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@simple-is.20150623.gappssmtp.com header.s=20150623 header.b=wUayvAXN;
       spf=neutral (google.com: 209.85.220.41 is neither permitted nor denied by best guess record for domain of hulda@simple.is) smtp.mailfrom=hulda@simple.is
Return-Path: <hulda@simple.is>
Received: from mail-sor-f41.google.com (mail-sor-f41.google.com. [209.85.220.41])
        by mx.google.com with SMTPS id f6sor5516467qvt.51.2020.04.11.05.17.57
        for <josh@josh.is>
        (Google Transport Security);
        Sat, 11 Apr 2020 05:17:57 -0700 (PDT)
Received-SPF: neutral (google.com: 209.85.220.41 is neither permitted nor denied by best guess record for domain of hulda@simple.is) client-ip=209.85.220.41;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@simple-is.20150623.gappssmtp.com header.s=20150623 header.b=wUayvAXN;
       spf=neutral (google.com: 209.85.220.41 is neither permitted nor denied by best guess record for domain of hulda@simple.is) smtp.mailfrom=hulda@simple.is
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed;
        d=simple-is.20150623.gappssmtp.com; s=20150623;
        h=from:content-transfer-encoding:mime-version:date:subject:message-id
         :to;
        bh=O2tvPxJjUEQcqtf7Ql+o/9C5dUgclQDTO0bXqiOMEgU=;
        b=wUayvAXNAZP/LM73G+ioiPRox6Akh+8Zj9+KUX4lOgieV2bDnmIQLU99tjdDbark8y
         AQG6K4dLbmOnYBdI6cGSyaoiRG77CGxMoN/+5OSy9DGxr222DbtQ7mlVTvub5SYbLnD6
         y+y0w/ib2XXbG2UJzN0FeV88ukEW8KGeSrz2S784nEaivFuEHlvtaSZi0xz5Wv3XlKfh
         VN44+kP4W+HJDJos9suOvXoCQJ6ke1qWSOFGgo5E/gxiIB/sZPkHk0ZOSG9Xkj1M9Odz
         qk4z7bzUUqBDt+Qgwc8vAKf0GRj4JaaAcQuHSnzSpCNgX0s5WdmFVpY6X5u4Mm/6yVG9
         CGcw==
X-Google-DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed;
        d=1e100.net; s=20161025;
        h=x-gm-message-state:from:content-transfer-encoding:mime-version:date
         :subject:message-id:to;
        bh=O2tvPxJjUEQcqtf7Ql+o/9C5dUgclQDTO0bXqiOMEgU=;
        b=tAU6nELx5UQI3GAugrnUimu6AFCS/dfeb4qv3S7kE6kKugcCT3DdXymn9L765ljRgt
         1hMCNvZSBkr2bNsYStEaciKNNjZcAPPvV6/HVxc6N/jZISo9cRHBc6d2kfarwENibdDI
         T8tgd1glZi/IVewKFy88880/AJkZOD6GMDtNtmgmr5qUEsu7HtFC06Yw5z9ich3lE28R
         14Km+yfa9LtSEy3LBAPhDCMOzYgYWyGWsG7OXwNxAf5/7g3IWyVmoXLzkxG6YvuIUPOa
         TAVvzh2nYaPhuwDiavS9RErciqvxvcu1Hkpb18ElmTEAxoqdwS6ER6N3G2ZSAwk+OIcx
         E3Yw==
X-Gm-Message-State: AGi0PuYKcOBu/2mt2fq4taJViPNstdbHB2UEHyt8RjhvWlwq439z3C2/
	pEpieEcGbI2v6spXWRNHoT26ruUqqrk=
X-Google-Smtp-Source: APiQypJsmx/m4aY1BSESHI3DSAJicBYV3aZ59CeJsfxCvzTUlWcuPEwQnmsarhb7ZJMuLTNjyqSaQg==
X-Received: by 2002:a0c:9b95:: with SMTP id o21mr9190547qve.175.1586607476990;
        Sat, 11 Apr 2020 05:17:56 -0700 (PDT)
Return-Path: <hulda@simple.is>
Received: from [172.16.0.9] (cpe-66-108-48-149.nyc.res.rr.com. [66.108.48.149])
        by smtp.gmail.com with ESMTPSA id m26sm3754141qta.53.2020.04.11.05.17.56
        for <josh@josh.is>
        (version=TLS1_3 cipher=TLS_AES_128_GCM_SHA256 bits=128/128);
        Sat, 11 Apr 2020 05:17:56 -0700 (PDT)
From: "Hulda@simple.is" <hulda@simple.is>
X-Google-Original-From: "Hulda@simple.is" <Hulda@simple.is>
Content-Type: multipart/alternative; boundary=Apple-Mail-A1ABE46D-9768-4297-92B3-ECFDC379E50A
Content-Transfer-Encoding: 7bit
Mime-Version: 1.0 (1.0)
Date: Sat, 11 Apr 2020 08:17:55 -0400
Subject: Bloomberg: Two-thirds of severe COVID-19 cases improved on experimental drug, early analysis shows
Message-Id: <626630C2-3795-480F-8F01-62082B2CE465@simple.is>
To: Josh Klein <josh@josh.is>
X-Mailer: iPhone Mail (17D50)


--Apple-Mail-A1ABE46D-9768-4297-92B3-ECFDC379E50A
Content-Type: text/plain;
	charset=utf-8
Content-Transfer-Encoding: quoted-printable


Two-thirds of severe COVID-19 cases improved on experimental drug, early ana=
lysis shows
Gilead Sciences Inc.=E2=80=99s experimental drug for patients with severe Co=
vid-19 infections showed promise in an early analysis, raising tentative hop=
e that the first treatment for the novel virus may be on the horizon.

Read in Bloomberg: https://apple.news/AAKlZCtGORR--5Vbpgp9zyA


Shared from Apple News

--Apple-Mail-A1ABE46D-9768-4297-92B3-ECFDC379E50A
Content-Type: text/html;
	charset=utf-8
Content-Transfer-Encoding: quoted-printable

<html><head><meta http-equiv=3D"content-type" content=3D"text/html; charset=3D=
utf-8"></head><body dir=3D"auto"><div dir=3D"ltr"><br><strong>Two-thirds of s=
evere COVID-19 cases improved on experimental drug, early analysis shows</st=
rong><br>Gilead Sciences Inc.=E2=80=99s experimental drug for patients with s=
evere Covid-19 infections showed promise in an early analysis, raising tenta=
tive hope that the first treatment for the novel virus may be on the horizon=
.<br><br>Read in  Bloomberg: <a href=3D"https://apple.news/AAKlZCtGORR--5Vbp=
gp9zyA">https://apple.news/AAKlZCtGORR--5Vbpgp9zyA</a><br><br><br>Shared fro=
m <a href=3D"https://www.apple.com/news">Apple News</a><br></div></body></ht=
ml>=

--Apple-Mail-A1ABE46D-9768-4297-92B3-ECFDC379E50A--
